Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Cash & Current Investments (2016 - 2025)

CorMedix (CRMD) has disclosed Cash & Current Investments for 14 consecutive years, with $155.2 million as the latest value for Q4 2025.

  • Quarterly Cash & Current Investments rose 200.27% to $155.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $155.2 million through Dec 2025, up 200.27% year-over-year, with the annual reading at $155.2 million for FY2025, 200.27% up from the prior year.
  • Cash & Current Investments hit $155.2 million in Q4 2025 for CorMedix, up from $55.7 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $190.7 million in Q2 2025 to a low of $19.8 million in Q2 2023.
  • Historically, Cash & Current Investments has averaged $67.5 million across 5 years, with a median of $55.7 million in 2025.
  • Biggest five-year swings in Cash & Current Investments: skyrocketed 342.79% in 2021 and later tumbled 68.91% in 2022.
  • Year by year, Cash & Current Investments stood at $53.4 million in 2021, then decreased by 19.04% to $43.3 million in 2022, then skyrocketed by 100.1% to $86.6 million in 2023, then plummeted by 40.31% to $51.7 million in 2024, then soared by 200.27% to $155.2 million in 2025.
  • Business Quant data shows Cash & Current Investments for CRMD at $155.2 million in Q4 2025, $55.7 million in Q3 2025, and $190.7 million in Q2 2025.